Members Members Residents Job Board
Join Today Renew Your Membership Make A Donation
2004 Abstract: NON-OBESE DIABETIC MICE HAVE DIMINISHED GALLBLADDER MOTILITY

NON-OBESE DIABETIC MICE HAVE DIMINISHED GALLBLADDER MOTILITY

Publishing Number: 273

Shannon J. Graewin, James M. Kiely, Keun-Ho Lee, Attila Nakeeb, Henry A. Pitt, Medical College of Wisconsin, Milwaukee, WI

Background: Both diabetes and obesity are associated with an increased risk of cholesterol gallstones. However, the relative importance of these two risk factors is difficult to determine as obesity and diabetes are strongly associated. Previous studies from this laboratory with leptin-deficient (Lepob) and leptin-resistant (Lepdb) obese mice have demonstrated decreased gallbladder motility that correlates with increasing body weight as well as serum glucose and insulin levels. However, the relative role of diabetes, obesity, or an abnormal leptin pathway in biliary motility remains unclear. Therefore, we tested the hypothesis that leptin-normal, non-obese diabetic (NOD) mice would have reduced gallbladder motility. Methods: Eight-week old lean control (C57BL/6J, n=10) and NOD (n=10) mice were fed a non-lithogenic chow diet for four weeks. All animals were fasted overnight and underwent cholecystectomies. Bile was aspirated from the intact gallbladder, and the volume (μl) was recorded. Contractile response (N/cm2) to acetylcholine (Ach 10-5M), neuropeptide Y (NPY 10-8,-7,-6M), and cholecystokinin (CCK 10-10,-9,-8,-7M) was measured. Results were analyzed using the Mann-Whitney Rank Sum Test and are displayed in the table. Conclusions: These data suggest that leptin-normal, non-obese diabetic mice have 1) similar gallbladder volume but 2) diminished response to acetylcholine, neuropeptide Y, and cholecystokinin compared to the lean control mice. Therefore, we conclude that diabetes, in the absence of obesity or altered leptin function, is associated with abnormal biliary motility. Thus, diabetes may provide a link between obesity, altered biliary motility, and gallstone formation.

 

Wt (g) 

GB Vol (μl) 

ACh-5 

NPY-6 

CCK-8 

Lean 

17.3 ± 0.2 

13 ±

.24 ± .04 

.08 ± .02 

.75 ± .14 

NOD 

19.6 ± 0.4* 

16 ±

.05 ± .01* 

.02 ± .01* 

.37 ± .09 

*p<0.01, p<0.05 vs C57b lean controls

 




Society for Surgery of the Alimentary Tract

Facebook Twitter YouTube

Email SSAT Email SSAT
500 Cummings Center, Suite 4400, Beverly, MA 01915 500 Cummings Center
Suite 4400
Beverly, MA 01915
+1 978-927-8330 +1 978-927-8330
+1 978-524-0498 +1 978-524-0498
Links
About
Membership
Publications
Newsletters
Annual Meeting
Join SSAT
Job Board
Make a Pledge
Event Calendar
Awards